Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
Trackers› Clinical trials› Warsaw
Clinical trial register · Poland

Clinical Trials in Warsaw, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Poland and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 2705 matching records held by the registry are in this view. Synced 28 Oct 2026, 03:18 UTC
2705
Studies in scope
all four open statuses
1389
Recruiting now
open to new participants
512
Lead sponsors
across recruiting studies
Top sites
Warsaw 21 Poznan 15 Krakow 15 Gdansk 13 Lodz 12
Narrow the registerReset
Recruitment status
Phase
Site location
Warsaw21 Poznan15 Krakow15 Gdansk13 Lodz12
All 41 locations
Target enrolment
to

Trials with a site in Warsaw

21 of 2705 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Poland
Start
Recruiting
Amgen
Phase 2
30
Warsaw
2026-05-07
Active, closed
Amgen
Phase 3
250
Bialystok, Poznan, Warsaw
2025-12-19
Active, closed
Amgen
Phase 3
250
Bialystok, Poznan, Warsaw
2025-11-25
Active, closed
Amgen
Phase 3
350
Bystra, Gdansk, Warsaw
2025-08-18
Active, closed
Amgen
Phase 3
3,853
Bialystok, Dębica, Gdynia, Katowice, Lodz, Lublin, Poznan, Warsaw
2025-03-12
Recruiting
Amgen
Phase 3
844
Poznan, Krakow, Wroclaw, Lublin, Warsaw, Wołomin, Malbork, Bydgoszcz
2025-02-25
Active, closed
Comparison Between ABP 692 and Ocrevus® (Ocrelizumab)
NCT06700343Relapsing-remitting Multiple Sclerosis (RRMS)
Amgen
Phase 3
152
Bydgoszcz, Katowice, Kielce, Krakow, Lodz, Lublin, Poznan, Warsaw
2025-01-13
Active, closed
Amgen
Phase 2
409
Bialystok, Krakow, Lublin, Staszów, Warsaw, Wroclaw
2024-11-07
Active, closed
Amgen
Phase 3
563
Gdansk, Poznan, Warsaw, Wroclaw
2024-06-05
Active, closed
Amgen
Phase 1/2
94
Gdansk, Poznan, Swidnica, Warsaw
2024-05-30
Active, closed
Amgen
Phase 3
434
Krakow, Wroclaw, Lublin, Warsaw, Wołomin, Malbork, Bydgoszcz, Katowice
2024-04-08
Active, closed
Amgen
Phase 4
32
Warsaw, Katowice
2024-04-02
Active, closed
Study Evaluating Tarlatamab After Chemoradiotherapy in Limited-Stage Small-Cell Lung Cancer (LS-SCLC)
NCT06117774Limited Stage Small Cell Lung Cancer, Small Cell Lung Cancer
Amgen
Phase 3
404
Bialystok, Bystra, Gdansk, Lublin, Poznan, Prabuty, Przemyśl, Warsaw
2024-02-20
Recruiting
A Study to Evaluate Avacopan in Participants With ANCA-associated Vasculitis
NCT06072482Antineutrophil Cytoplasmic Antibody-associated Vasculitis
Amgen
Phase 4
300
Lodz, Warsaw
2024-02-07
Recruiting
Amgen
Phase 3
60
Krakow, Lodz, Warsaw
2022-03-17
Active, closed
Amgen
Phase 3
135
Warsaw, Wroclaw
2020-12-04
Active, closed
Myasthenia Gravis Inebilizumab Trial
NCT04524273Myasthenia Gravis
Amgen
Phase 3
238
Katowice, Krakow, Poznan, Warsaw
2020-10-15
Active, closed
Amgen
Phase 3
457
Bydgoszcz, Poznan, Warsaw, Wroclaw
2019-07-19
Rows per page Showing 1–21 of 21
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Polish investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 30 October 2026. https://priyalifescience.com/clinical-trials-poland/city/warsaw

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Poland and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 2,705 studies in total at the last sync on 28 Oct 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 21 of those studies with a site in Warsaw that also match the filters currently applied.

How many clinical trials are recruiting in Warsaw?

5 of the 21 studies on this page are recruiting new participants as of the 28 Oct 2026, 03:18 UTC sync. A further 1 have not yet opened recruitment, 15 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Warsaw), 21 studies
PhaseStudiesRecruitingShare
Phase 315371.4%
Phase 23114.3%
Phase 4219.5%
Phase 1/2104.8%

Most active sponsors

Lead sponsors with the most studies (Warsaw)
Lead sponsorStudiesRecruiting
Amgen215
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.